Prescription Treatment for Yeast Infection (Vulvovaginal Candidiasis)
For uncomplicated vulvovaginal candidiasis, oral fluconazole 150 mg as a single dose is the most convenient and equally effective prescription option compared to topical agents 1, 2.
First-Line Prescription Options
The prescription treatments for uncomplicated VVC include:
Oral Therapy (Most Convenient)
- Fluconazole 150 mg single oral dose - This is the standard prescription option that achieves >90% response rates and is as effective as topical regimens 2
- Recent network meta-analysis shows single-dose fluconazole has the highest probability of achieving early (SUCRA=74.1%) and late (SUCRA=84.2%) mycological cure 3
Prescription Topical Agents
While many topical azoles are available over-the-counter, prescription-strength options include:
- Terconazole 0.4% cream - 5 grams intravaginally daily for 7 days 1
- Terconazole 0.8% cream - 5 grams intravaginally daily for 3 days 1
- Terconazole 80 mg vaginal suppository - One suppository daily for 3 days 1
No single topical agent is superior to another - all achieve equivalent clinical outcomes 2.
When to Escalate Treatment
Severe Acute VVC
Fluconazole 150 mg every 72 hours for 2-3 total doses is recommended for severe presentations 2.
Recurrent VVC (≥3 episodes in 12 months)
This requires a two-phase approach 2:
- Induction phase: 10-14 days of topical azole OR oral fluconazole
- Maintenance phase: Fluconazole 150 mg weekly for 6 months (strong recommendation)
Non-albicans Species (C. glabrata)
When unresponsive to oral azoles 2:
- Boric acid 600 mg intravaginal capsules daily for 14 days (strong recommendation)
- Alternative: Nystatin intravaginal suppositories 100,000 units daily for 14 days
Key Clinical Pearls
Confirm the diagnosis before prescribing - Less than half of patients treated for VVC actually have the condition when objective testing is used 1. Wet mount with KOH or PCR testing (sensitivity 90.9%, specificity 94.1%) is far superior to clinical diagnosis alone 1.
Oral and topical formulations are equally effective - The choice between them should be based on patient preference, cost, and convenience rather than efficacy 2. However, the most recent meta-analysis suggests oral fluconazole has a marginal advantage in early clinical cure (OR=1.52) and late mycological cure (OR=1.42) compared to multiple-day topical therapy 3.
Itraconazole is an alternative - Multiple-day itraconazole scored highest for symptom relief in ranking analysis (SUCRA=99% early, 75.7% late) 3, though it's less commonly prescribed than fluconazole. Meta-analysis shows similar effectiveness and safety between itraconazole and fluconazole 4.
Common Pitfalls to Avoid
- Don't treat empirically without confirmation - Symptoms are nonspecific and can represent other infectious or noninfectious etiologies 2
- Don't use the same regimen for complicated VVC - These cases require longer duration therapy (7-14 days) 2
- Don't assume all yeast infections are C. albicans - If treatment fails, culture to identify non-albicans species that may require different management 1, 2